5AM Venture Management »

Mersana Therapeutics shares owned by 5AM Venture Management

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by 5AM Venture Management from 13F filings

Historical chart of 5AM Venture Management investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by 5AM Venture Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by 5AM Venture Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $405k 52k 7.76

More positions owned by 5AM Venture Management

Skye Bioscience Com New (SKYE)
Entrada Therapeutics (TRDA)
Pharvaris N V (PHVS)
Camp4 Therapeutics Corp (CAMP)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Miragen Therapeutics (VRDN)
Enliven Therapeutics (ELVN)
Eyepoint Pharmaceuticals Com New (EYPT)
Dianthus Therapeutics (DNTH)
Tyra Biosciences (TYRA)
Celldex Therapeutics Com New (CLDX)
Erasca (ERAS)
Praxis Precision Medicines I Com New (PRAX)
Gh Research Ordinary Shares (GHRS)
Tectonic Therapeutic (TECX)

View all positions for 5AM Venture Management

Top funds holding Mersana Therapeutics

Nextech Invest
Alamea Verwaltungs GmbH
Bain Capital Life Sciences Investors
Vanguard Group
Schonfeld Strategic Advisors
Rock Springs Capital Management
Acadian Asset Management
Silverarc Capital Management
683 Capital Management
BlackRock
Renaissance Technologies
Millennium Management
5AM Venture Management
Mackenzie Financial
AQR Capital Management

View all funds holding Mersana Therapeutics